Today: 15 May 2026

Eli Lilly’s New Weight-Loss Pill Has an Early Problem: Novo’s Head Start

Eli Lilly’s New Weight-Loss Pill Has an Early Problem: Novo’s Head Start

Eli Lilly’s new oral weight-loss drug Foundayo was prescribed 3,707 times in its second week on the U.S. market, well below Novo Nordisk’s oral Wegovy, which saw 18,410 prescriptions in the same period after launch. Lilly shares fell about 4% following the data, while Novo Nordisk’s U.S. shares rose nearly 6%. Foundayo was approved by the FDA on April 1 and began shipping April 6.
24 April 2026
···
Why Cheetah Net Stock Jumped Today: CTNT Deal, Heavy Volume and Dilution Risk

Why Cheetah Net Stock Jumped Today: CTNT Deal, Heavy Volume and Dilution Risk

Cheetah Net Supply Chain Service Inc. shares surged Friday, trading over 2.09 billion shares after the company agreed to buy Hong Kong-based Super International Trading Limited for $4.98 million in cash. The stock rose to $0.0547, up 2.16 cents. The deal includes a $10 million annual revenue commitment from the target. Cheetah recently set up a $70 million at-the-market stock sale program.
24 April 2026
·
Keel Infrastructure’s Paraguay Sale Puts Former Bitfarms’ AI Data Center Bet on the Clock

Keel Infrastructure’s Paraguay Sale Puts Former Bitfarms’ AI Data Center Bet on the Clock

Keel Infrastructure Corp. sold its 70-megawatt Paso Pe site in Paraguay for about $13 million, well below the original price of up to $30 million, finalizing its exit from Latin America. The sale follows Keel’s U.S. redomiciliation and rebrand from Bitfarms as it shifts from Bitcoin mining to AI data-center infrastructure. Keel shares rose 5.4% to $3.42 in New York. The company reported a net loss of $284.5 million for 2025.
24 April 2026
·····
Tempus AI Stock Faces a New Test as USC Deal Opens a 1.5 Million-Visit Door

Tempus AI Stock Faces a New Test as USC Deal Opens a 1.5 Million-Visit Door

Tempus AI Inc. announced a collaboration with the Keck School of Medicine of USC to integrate its molecular testing and trial-matching tools into USC’s health system, covering over 1.5 million patient visits annually. Financial terms were not disclosed. Tempus shares traded at $51.70 midday Friday, valuing the company at about $9 billion. The partnership will initially focus on precision oncology across USC hospitals and clinics.
24 April 2026
·
Novo Nordisk Stock Gets Wegovy Pill Boost as Eli Lilly’s Foundayo Starts Slow

Novo Nordisk Stock Gets Wegovy Pill Boost as Eli Lilly’s Foundayo Starts Slow

Novo Nordisk’s Wegovy pill recorded 18,410 U.S. prescriptions in its second week, far outpacing Eli Lilly’s Foundayo at 3,707, according to IQVIA data cited by analysts. Novo’s shares rose $2.24 to $40.76, while Lilly’s fell $35.26 to $882.39. Novo said its oral semaglutide lowered HbA1c by 0.83 points more than placebo in a trial of adolescents with type 2 diabetes. The company plans to seek regulatory approval for pediatric use in 2026.
24 April 2026
··
Nvidia Stock Is Near a Record Again. The $300 Case Now Turns on Vera Rubin

Nvidia Stock Is Near a Record Again. The $300 Case Now Turns on Vera Rubin

Nvidia shares rose 4.7% to $209.07 Friday, nearing record highs ahead of its May 20 earnings report. Investors are focused on demand for Nvidia’s upcoming Vera Rubin AI platform and whether cloud customers will keep spending into 2027. The Philadelphia Semiconductor Index hit an all-time high as chip stocks rallied after Intel’s strong outlook. Nvidia reported $68.1 billion in fiscal Q4 revenue, up 73% from a year earlier.
24 April 2026
···
POET Stock Is Flying Again: The Marvell Link, AI Optics Buzz and Tax Fight Behind the Rally

POET Stock Is Flying Again: The Marvell Link, AI Optics Buzz and Tax Fight Behind the Rally

POET Technologies shares rose 27% to $14.93 in late-morning trading Friday after CFO Thomas Mika said the company received a purchase order linked to Marvell Technology. Marvell has not confirmed the order. POET reported $341,202 in Q4 revenue and a $42.7 million net loss, as it shifts from development to production. The rally follows news of Marvell’s acquisition of Celestial AI and reported Google talks.
24 April 2026
··
Scinai Stock Surges on $2.61 Million Private Placement as SCNI Bets on CDMO Expansion

Scinai Stock Surges on $2.61 Million Private Placement as SCNI Bets on CDMO Expansion

Scinai Immunotherapeutics shares soared 82% Friday after the company announced a $2.61 million private placement and warrant inducement to fund its contract drug-manufacturing and immunotherapy work. The financing includes the sale of 5.2 million ADSs at $0.48 each and new warrants, with closing expected around April 27. Scinai reported $1.6 million cash at year-end and a going-concern warning in its latest filing.
24 April 2026
·
Norfolk Southern Stock Slips as Fuel Shock Puts Its Profit Story to the Test

Norfolk Southern Stock Slips as Fuel Shock Puts Its Profit Story to the Test

Norfolk Southern reported first-quarter net income of $547 million, down from $750 million a year earlier, citing higher fuel costs and merger expenses. Revenue held steady at $3.0 billion, but operating income dropped to $877 million. Shares fell 0.5% as investors focused on fuel price pressures and weak freight volumes. Intermodal traffic slipped 4%, while coal tonnage rose 9% but brought in less revenue.
24 April 2026
···
Synopsys Stock Turns Back Toward AI Chip Race After New TSMC Design Push

Synopsys Stock Turns Back Toward AI Chip Race After New TSMC Design Push

Synopsys announced expanded collaboration with TSMC on advanced chipmaking and packaging for AI, unveiling new design and analysis tools for TSMC’s 3nm, 2nm, A16, and A14 nodes. Shares of Synopsys rose to $483.00 early Friday after an eight-day winning streak ended Thursday. Cadence and Siemens also updated TSMC-related design tools. The news coincided with TSMC’s North America Technology Symposium in Santa Clara.
24 April 2026
···
Joby Aviation’s LA Air Taxi Bet Gets a Rooftop Test as Investors Watch Certification

Joby Aviation’s LA Air Taxi Bet Gets a Rooftop Test as Investors Watch Certification

Reuben Brothers and Joby Aviation announced plans for an air-taxi vertiport at Park Elm Residences at Century Plaza in Los Angeles, using the South Tower’s helipad and adding charging and a passenger lounge. The project requires local, state, and federal approvals. Joby is still seeking commercial certification for its electric aircraft. Residents would be able to book flights within the Los Angeles area.
24 April 2026
··
Qualcomm Stock Jumps Before April 29 Earnings, But the AI Trade Has a Hard Test Ahead

Qualcomm Stock Jumps Before April 29 Earnings, But the AI Trade Has a Hard Test Ahead

Qualcomm shares surged 9.7% to $146.97 in early Friday trading ahead of its April 29 earnings report. The company forecasts fiscal Q2 revenue of $10.2–$11 billion and adjusted EPS of $2.45–$2.65, with handset chip sales near $6 billion. JPMorgan downgraded the stock, citing smartphone headwinds and data-center competition. Adobe traded nearly flat at $238.76 after a large buyback.
24 April 2026
··
American Express Stock Is Falling After a Q1 Earnings Beat. The Catch Is Travel.

American Express Stock Is Falling After a Q1 Earnings Beat. The Catch Is Travel.

American Express reported first-quarter earnings per share of $4.28, up 18%, and revenue of $18.9 billion, an 11% increase. Shares fell 4.3% premarket to $318.55 as investors focused on higher expenses and softer airline spending. Net income rose to $3.0 billion, while billed business climbed 9% to $428 billion. The company reaffirmed its 2026 outlook and plans increased marketing and technology spending.
24 April 2026
····
1 … 74 75 76 77 78 … 1,941

Stock Market Today

  • PDD Holdings Shares Show Potential Upside After Recent Decline
    May 15, 2026, 4:17 PM EDT. PDD Holdings (PDD) shares have dropped 5.8% over the past week and 17.4% year-to-date, stirring debate on whether the stock is undervalued or a value trap. A Discounted Cash Flow (DCF) analysis projects an intrinsic value of US$175.29 per share, suggesting PDD trades at a 45.5% discount to fair value. The company's recent free cash flow stands at approximately CN¥105.9 billion, with expected growth through 2035. Despite a -18.9% return last year lagging peers, valuation metrics indicate PDD may offer an opportunity as investors reassess growth and risks in the multiline retail sector. Analysts recommend monitoring PDD's price relative to earnings and cash flow forecasts before making investment decisions.

Latest articles

P3 Health Partners Stock Surges After Q1 Profit Swing, 2026 Outlook Raise

15 May 2026
HENDERSON, Nevada, May 15, 2026, 13:03 PT Shares of P3 Health Partners Inc. more than tripled in late Friday trading after the Medicare-focused care company posted a first-quarter profit and lifted its 2026 adjusted EBITDA outlook. The stock was recently at $13.00, up from a $4.03 prior close, after touching $14.08 intraday, market data showed. The move matters because P3 has been trying to prove that its value-based care model can generate earnings after years of losses. In a filing, the company said it had experienced losses since inception until the March quarter and still held only $25.5 million in
Dow Jones Today: Dow Drops 406 Points as Oil Shock Revives Fed-Hike Fear

Dow Jones Today: Dow Drops 406 Points as Oil Shock Revives Fed-Hike Fear

15 May 2026
The Dow Jones Industrial Average fell 406.40 points to 49,657.06 on Friday, slipping below 50,000 after oil prices and Treasury yields rose. The S&P 500 lost 50.23 points and the Nasdaq dropped 195.89. Prediction markets now show high odds of no Federal Reserve rate cuts in 2026. Ten of 11 major S&P sectors declined, with energy the only gainer.
Dow Sinks 406 Points; AI Surge Stalls as Oil Shock Hits US Market

Dow Sinks 406 Points; AI Surge Stalls as Oil Shock Hits US Market

15 May 2026
U.S. stocks fell Friday, with the Dow down 406.40 points and the S&P 500 and Nasdaq also lower, as oil prices surged and inflation concerns hit AI-linked shares. Brent crude settled at $109.26 a barrel, up 3.35%. The 10-year Treasury yield climbed to 4.58%. Energy was the only S&P 500 sector to rise, while semiconductor stocks dropped sharply.
AT&T, Verizon, T-Mobile Rally Against Dead Zones With Uncommon Satellite Move, Eye Starlink Push

AT&T, Verizon, T-Mobile Rally Against Dead Zones With Uncommon Satellite Move, Eye Starlink Push

15 May 2026
AT&T, Verizon, and T-Mobile announced plans to jointly build a satellite-based network to eliminate U.S. wireless dead zones, aiming to connect ordinary phones directly to satellites. The move follows the FCC’s approval of EchoStar’s $40 billion spectrum sale to SpaceX and AT&T. The carriers have an agreement in principle but have not finalized terms. AT&T reported $31.5 billion in Q1 revenue and $126.4 billion in net debt.
Go toTop